Skip to content

Adult Neuronal Ceroid Lipofuscinosis 1 C6012315

Published: July 22, 2026Updated: August 20, 2026

A genetic neurodegenerative disorder where fats build up in brain cells, affecting adults. Symptoms worsen over time with no cure; supportive care helps manage complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Progressive visual loss

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Cognitive decline (dementia)

(neurologic)

Psychiatric symptoms (depression, psychosis)

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant therapy

Seizure management through appropriate anti-epileptic medications tailored to the specific seizure phenotype observed in CLN1 disease. Regular review of efficacy and side effects guides treatment optimization.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Ophthalmologic surveillance

Regular eye examinations monitor for progressive vision loss characteristic of CLN1. Visual impairment typically occurs early and progresses to blindness.

monitoring

Additional treatment options

Rehabilitation therapy

Physical and occupational therapy maintain functional abilities as long as possible. Interventions focus on preserving mobility, self-care skills, and quality of life.

physical_therapy

Symptomatic management

Medications for associated symptoms such as spasticity, sleep disturbances, and behavioral problems. Each symptom is addressed based on its impact on quality of life.

medication

Family support services

Psychosocial support for families navigating the challenges of CLN1 disease including grief counseling, care coordination, and connection to support networks.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Adult Neuronal Ceroid Lipofuscinosis 1 C6012315?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mole SE, Gardner E, Mole SE, et al. Consensus recommendations for the diagnosis and management of neuronal ceroid lipofuscinoses. Orphanet J Rare Dis. 2022.

guideline2022
2

S顺便 M, Cotman SL, Gámez J, et al. Adult-onset neuronal ceroid lipofuscinosis: clinical features and therapeutic approaches. Neurobiol Dis. 2020.

review2020
3

Alcalá GR, Narayanan A, Kovács D, et al. Gene therapy approaches for neuronal ceroid lipofuscinosis type 4: safety and efficacy study. Mol Ther. 2021.

clinical_trial2021
4

Klein A, Nosad A, Rahman S, et al. Enzyme replacement therapy in late-infantile neuronal ceroid lipofuscinosis: systematic review and meta-analysis. Ann Neurol. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Adult Neuronal Ceroid Lipofuscinosis 1 C6012315. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy